Impaired thyroid hormone sensitivity is associated with cardiovascular disease risk and mortality in euthyroid subjects
- 1Department of Surgery, Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
- 2Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Abstract
Background Fluctuations in thyroid function among euthyroid individuals have been linked to cardiovascular disease (CVD). We investigated whether central thyroid hormone sensitivity correlates with CVD risk, CVD-related death, and overall mortality in subjects with normal thyroid function, particularly examining how age modifies these associations. Methods We analyzed data from 6,374 euthyroid adults enrolled in NHANES 2007–2012. Central thyroid hormone sensitivity was quantified using three indices: the thyroid feedback quantile-based index (TFQI), the thyrotropin-thyroxine resistance index (TT4RI) and the TSH index (TSHI). The Framingham Risk Score (FRS) estimated each participant’s 10-year probability of developing CVD. CVD mortality and all-cause mortality were ascertained by linkage to the National Death Index through December 31, 2015. Associations were evaluated using logistic regression (10-year CVD risk) and Cox proportional hazards models (mortality), adjusted for sex and race, with analyses stratified by age (< 40 and ≥ 40 years). Results Of the 6,374 participants (mean age 48.24 ± 17.59 years; 52.0% male), 18.5% had a 10-year CVD risk > 10%; during follow-up. In sex- and race-adjusted models, all three indices were positively associated with an elevated 10-year CVD risk (> 10%): TFQI (OR 1.40, 95% CI 1.15–1.71), TSHI (OR 1.27, 95% CI 1.11–1.45), and TT4RI (OR 1.01, 95% CI 1.01–1.02). Each index was also significantly associated with higher CVD mortality and all-cause mortality, with TFQI showing the strongest associations (CVD mortality: HR 3.30, 95% CI 2.24–4.85; all-cause mortality: HR 2.19, 95% CI 1.83–2.62). These associations remained significant in participants aged ≥ 40 years (p < 0.001) but not in those aged < 40 years. Conclusion Impaired central thyroid hormone sensitivity shows association with elevated CVD risk, CVD mortality, and all-cause mortality in euthyroid individuals aged 40 years and older. Graphical abstract
Related
- Factors Associated With Uncontrolled Blood Pressure and Its Association With Cardiovascular and All-Cause Mortality Among Adults Receiving Antihypertensive Therapy: A Retrospective Cohort Study Using NHANES 2013-2018 Linked Mortality Data
- Metabolic Dysfunction-Associated Fatty Liver Disease-Cardiovascular-Kidney-Metabolic (MAFLD-CKM): A Modified Framework to Predict Long-Term Mortality.
- Temporal trends and disparities in mesenteric ischemia–associated cardiovascular mortality among U.S. adults aged ≥45 years, 1999–2023
- Preclinical carotid atherosclerosis is independently associated with cardiovascular events and mortality in type 1 diabetes.
- Elevated FT4 is associated with prevalent stroke in euthyroid adults: a cross‑sectional study
BibTeX
@article{jiao2026impaired,
title = {{Impaired thyroid hormone sensitivity is associated with cardiovascular disease risk and mortality in euthyroid subjects}},
author = {Yang Jiao and Juan Sun and Yuanmeng Li and Feng Mao},
journal = {Journal of Cardiothoracic Surgery},
year = {2026},
month = jul,
doi = {10.1186/s13019-026-04589-6},
url = {https://doi.org/10.1186/s13019-026-04589-6},
note = {CC BY},
}
RIS
TY - JOUR
TI - Impaired thyroid hormone sensitivity is associated with cardiovascular disease risk and mortality in euthyroid subjects
AU - Yang Jiao
AU - Juan Sun
AU - Yuanmeng Li
AU - Feng Mao
PY - 2026
DA - 2026/07/01
JO - Journal of Cardiothoracic Surgery
DO - 10.1186/s13019-026-04589-6
UR - https://doi.org/10.1186/s13019-026-04589-6
AB - Background Fluctuations in thyroid function among euthyroid individuals have been linked to cardiovascular disease (CVD). We investigated whether central thyroid hormone sensitivity correlates with CVD risk, CVD-related death, and overall mortality in subjects with normal thyroid function, particularly examining how age modifies these associations. Methods We analyzed data from 6,374 euthyroid adults enrolled in NHANES 2007–2012. Central thyroid hormone sensitivity was quantified using three indices: the thyroid feedback quantile-based index (TFQI), the thyrotropin-thyroxine resistance index (TT4RI) and the TSH index (TSHI). The Framingham Risk Score (FRS) estimated each participant’s 10-year probability of developing CVD. CVD mortality and all-cause mortality were ascertained by linkage to the National Death Index through December 31, 2015. Associations were evaluated using logistic regression (10-year CVD risk) and Cox proportional hazards models (mortality), adjusted for sex and race, with analyses stratified by age (< 40 and ≥ 40 years). Results Of the 6,374 participants (mean age 48.24 ± 17.59 years; 52.0% male), 18.5% had a 10-year CVD risk > 10%; during follow-up. In sex- and race-adjusted models, all three indices were positively associated with an elevated 10-year CVD risk (> 10%): TFQI (OR 1.40, 95% CI 1.15–1.71), TSHI (OR 1.27, 95% CI 1.11–1.45), and TT4RI (OR 1.01, 95% CI 1.01–1.02). Each index was also significantly associated with higher CVD mortality and all-cause mortality, with TFQI showing the strongest associations (CVD mortality: HR 3.30, 95% CI 2.24–4.85; all-cause mortality: HR 2.19, 95% CI 1.83–2.62). These associations remained significant in participants aged ≥ 40 years (p < 0.001) but not in those aged < 40 years. Conclusion Impaired central thyroid hormone sensitivity shows association with elevated CVD risk, CVD mortality, and all-cause mortality in euthyroid individuals aged 40 years and older. Graphical abstract
SN - 1749-8090
ER -